loadpatents
name:-0.016623973846436
name:-0.0061788558959961
name:-0.00056600570678711
Fan; Sheung-Tat Patent Filings

Fan; Sheung-Tat

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fan; Sheung-Tat.The latest application filed is for "materials and methods for treatment of liver cancer".

Company Profile
0.8.16
  • Fan; Sheung-Tat - Hong Kong CN
  • Fan; Sheung Tat - Mid levels N/A HK
  • Fan; Sheung Tat - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Materials And Methods For Treatment Of Liver Cancer
App 20160039923 - Cheung; Siu Tim ;   et al.
2016-02-11
Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
Grant 9,207,242 - Luk , et al. December 8, 2
2015-12-08
Materials And Methods For Treatment Of Liver Cancer
App 20140356321 - Cheung; Siu Tim ;   et al.
2014-12-04
Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
App 20130315896 - Young; David S.F. ;   et al.
2013-11-28
Cytotoxicity mediation of cells evidencing surface expression of CD44
Grant 8,388,961 - Young , et al. March 5, 2
2013-03-05
Cytotoxicity Mediation of Cells Evidencing Surface Expression of CD44
App 20120020880 - Young; David S. F. ;   et al.
2012-01-26
Compositions and methods for prognosis and therapy of liver cancer
Grant 8,076,077 - Cheung , et al. December 13, 2
2011-12-13
Gep And Drug Transporter Regulation, Cancer Therapy And Prognosis
App 20110280862 - Cheung; Siu Tim ;   et al.
2011-11-17
Cytotoxicity mediation of cells evidencing surface expression of CD44
Grant 8,048,416 - Young , et al. November 1, 2
2011-11-01
Methods and compositions for treatment of endotoxin-mediated pro-inflammatory responses
Grant 7,960,338 - Luk , et al. June 14, 2
2011-06-14
Cadherin-17 As Diagnostic Marker And Therapeutic Target For Liver Cancer
App 20100092978 - Luk; Moon Ching John ;   et al.
2010-04-15
Methods And Compositions For Treatment Of Endotoxin-mediated Pro-inflammatory Responses
App 20100008925 - Luk; John Moon Ching ;   et al.
2010-01-14
Compositions And Methods For Prognosis And Therapy Of Liver Cancer
App 20090325160 - CHEUNG; SIU TIM ;   et al.
2009-12-31
Cytotoxicity mediation of cells evidencing surface expression of CD63
Grant 7,534,429 - Young , et al. May 19, 2
2009-05-19
The Use of Granulin-Epithelin Precursor (GEP) Anitbodies for Detection and Suppression of Hepatocellular Carcinoma (HCC)
App 20080199470 - Cheung; Siu Tim ;   et al.
2008-08-21
Cytotoxicity mediation of cells evidencing surface expression of CD44
App 20070248538 - Young; David S. F. ;   et al.
2007-10-25
Cytotoxicity mediation of cells evidencing surface expression of CD44
App 20070189964 - Young; David S.F. ;   et al.
2007-08-16
Cytotoxicity mediation of cells evidencing surface expression of CD63
App 20060269481 - Young; David S.F. ;   et al.
2006-11-30
Granulin-epithelin precursor (GEP) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (HCC)
App 20050244839 - Cheung, Siu Tim ;   et al.
2005-11-03
Compositions and methods for prognosis and therapy of liver cancer
App 20050089895 - Cheung, Siu Tim ;   et al.
2005-04-28
Adeno-associated virus mediated B7.1 vaccination synergizes with angiostatin to eradicate disseminated liver metastatic cancers
App 20040156828 - Xu, Ruian ;   et al.
2004-08-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed